Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features

Journal of the American Academy of Dermatology

Volumn 70, Issue 3, 2014, Pages 539-548

  Cho, Yung Tsu ^a   Lin, Jheng Wei ^b   Chen, Yi Chun ^c   Chang, Chia Ying ^a   Hsiao, Cheng Hsiang ^d   Chung, Wen Hung ^b   Chu, Chia Yu ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

fixed drug eruption; generalized bullous fixed drug eruption; granulysin; regulatory T cells; Stevens Johnson syndrome; toxic epidermal necrolysis

Indexed keywords

FIXED DRUG ERUPTION; GENERALIZED BULLOUS FIXED DRUG ERUPTION; GRANULYSIN; REGULATORY T CELLS; STEVENS-JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

AGED; AGED, 80 AND OVER; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PERFORIN; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SKIN DISEASES, VESICULOBULLOUS; STEVENS-JOHNSON SYNDROME; YOUNG ADULT;

EID: 84894057183     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.11.015     Document Type: Article

References (20)

1. E. Ozkaya Fixed drug eruption: state of the art J Dtsch Dermatol Ges 6 2006 181 188
2. V.N. Sehgal, and G. Srivastava Fixed drug eruption (FDE): changing scenario of incriminating drugs Int J Dermatol 45 2006 897 908 (Pubitemid 44145022)
3. + T cells in fixed drug eruption J Allergy Clin Immunol 112 2003 609 615 (Pubitemid 37108568)
4. + T cells during the evolution of fixed drug eruption Br J Dermatol 158 2008 1230 1238 (Pubitemid 351692861)
5. H.J. Choi, J.K. Ku, M.Y. Kim, H. Kang, S.H. Cho, and H.O. Kim et al. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption Br J Dermatol 154 2006 419 425 (Pubitemid 43382646)
6. T. Shiohara, and Y. Mizukawa Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells Eur J Dermatol 17 2007 201 208 (Pubitemid 46847781)
7. Y. Mizukawa, and T. Shiohara Nonpigmenting fixed drug eruption as a possible abortive variant of toxic epidermal necrolysis: immunohistochemical and serum cytokine analyses Clin Exp Dermatol 35 2010 493 497
8. A. Auquier-Dunant, M. Mockenhaupt, L. Naldi, O. Correia, W. Schroder, and J.C. Roujeau Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis Arch Dermatol 138 2002 1019 1024 (Pubitemid 34875605)
9. I. Viard, P. Wehrli, R. Bullani, P. Schneider, N. Holler, and D. Salomon et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 282 1998 490 493 (Pubitemid 28483679)
10. A. Nassif, A. Bensussan, G. Dorothee, F. Mami-Chouaib, N. Bachot, and M. Bagot et al. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis J Invest Dermatol 118 2002 728 733 (Pubitemid 34309997)
11. W.H. Chung, S.I. Hung, J.Y. Yang, S.C. Su, S.P. Huang, and C.Y. Wei et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis Nat Med 14 2008 1343 1350
12. R. Abe, N. Yoshioka, J. Murata, Y. Fujita, and H. Shimizu Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome Ann Intern Med 151 2009 514 515
13. Y. Fujita, N. Yoshioka, R. Abe, J. Murata, D. Hoshina, and H. Mae et al. Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis J Am Acad Dermatol 65 2011 65 68
14. S. Lipowicz, P. Sekula, S. Ingen-Housz-Oro, Y. Liss, B. Sassolas, and A. Dunant et al. Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis Br J Dermatol 168 2013 726 732
15. C.H. Lee, Y.C. Chen, Y.T. Cho, C.Y. Chang, and C.Y. Chu Fixed-drug eruption: a retrospective study in a single referral center in northern Taiwan Dermatologica Sinica 30 2012 11 15
16. S. Bastuji-Garin, B. Rzany, R.S. Stern, N.H. Shear, L. Naldi, and J.C. Roujeau Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme Arch Dermatol 169 1993 92 96 (Pubitemid 23029676)
17. K. Ogawa, Y. Takamori, K. Suzuki, M. Nagasawa, S. Takano, and Y. Kasahara et al. Granulysin in human serum as a marker of cell-mediated immunity Eur J Immunol 33 2003 1925 1933 (Pubitemid 37120864)
18. M. Nagasawa, T. Isoda, M. Kajiwara, T. Morio, N. Shimizu, and K. Ogawa et al. Analysis of serum granulysin in patients with hematopoietic stem-cell transplantation: its usefulness as a marker of graft-versus-host reaction Am J Hematol 81 2006 340 348
19. N. Saito, R. Abe, N. Yoshioka, J. Murata, Y. Fujita, and H. Shimizu Prolonged elevation of serum granulysin in drug-induced hypersensitivity syndrome Br J Dermatol 167 2012 452 453
20. S. Iwai, H. Sueki, H. Watanabe, Y. Sasaki, T. Suzuki, and M. Iijima Distinguishing between erythema multiforme major and Stevens-Johnson syndrome/toxic epidermal necrolysis immunopathologically J Dermatol 39 2012 1 6